Forbes

MLB shortstop Joshua Kuroda-Grauer of the Athletics suffered a ruptured testicle during a game against the Arizona Diamondbacks and required emergency surgical repair.

As HIV/AIDS enters its fifth decade, Black women's leadership offers urgent lessons about public health, community care, and democracy.

A ChatGPT misdiagnosis lawsuit claims AI advice nearly killed a man. A physician describes what peer-reviewed research shows about AI diagnostic accuracy.

The Bundibugyo strain of the Ebola virus has been devastating the Democratic Republic of the Congo, with no vaccine currently approved to protect against the strain.

Generative AI can identify ways around legal limits and safety filters governing mental health chats, raising new risks for users, lawmakers and AI companies.

After a June health scare, Simone Biles updates fans on a July medical procedure. Biles remains undecided on a 2028 Olympic run as former teammates Suni Lee and Katelyn Ohashi announce comebacks.

Three AI startups—Doctronic, Certuma and Ada Health—are racing to replace physicians. A physician describes their approach, Here's the data, funding and regulatory hurdles.

Measles, Cyclosporiasis and Ebola are spreading at unprecedented levels. All three are exposing vulnerabilities in global public health infrastructure.

“The continent should take the matter of resistance very, very seriously...Resistance should be seen as an emergency situation.”

What can American medicine learn from the dozens of teams that didn't win the World Cup in 2026? The answers include strategy, teamwork and leadership.

After 104 FIFA World Cup matches in 39 days, it’s only natural to feel like something’s been missing since the Final on July 19 with Spain beating Argentina 1-0.

When a hospital owns a doctor’s clinic, the same clinic visit can cost twice as much. What is site-neutral payment reform, and why is your doctor bill so high?

An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.

In this week’s edition of InnovationRx, we look at the companies looking to cash in on the coming peptide bonanza, the ongoing cyclosporiasis outbreak, Tempus’s acquisition of a cancer-testing company, and more.